Securing Management and Developing Successors
First written in FY2024. . Latest entry: FY2025.
3 other companies' latest entry also says "Other".
- FY2025Transfer of representative authorityAnnual report
「In particular, Jun Furukawa, chairperson of the Board of Directors, is the founder and has extensive experience and knowledge in supporting the management of medical institutions. He has led and grown the business since its founding. Hideo Misawa, representative director and president, plays a particularly important role in formulating, deciding and executing management policies and business strategies for the entire Group.」
Founder Jun Furukawa changed from representative director and chairperson to chairperson of the Board of Directors, and Hideo Misawa became representative director and president. Disclosure of dependence on the founder and president and succession risk continues. - FY2024First statedAnnual report
「Accordingly, the Group is strengthening its management organization by sharing information with officers and senior employees at Board of Directors meetings and elsewhere and delegating authority. By developing a management structure that does not rely excessively on the founder or certain directors, we are developing candidates for next-generation management and providing them with various experiences as part of our ongoing succession planning.」
The Group recognizes the need to reduce dependence on key individuals, including the founder and representative director and president, through delegation of authority and development of management candidates.